These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6307135)

  • 1. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    Antimicrob Agents Chemother; 1983 May; 23(5):731-7. PubMed ID: 6307135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone therapy of serious bacterial infections.
    Eron LJ; Park CH; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice daily ceftriaxone therapy for serious bacterial infections in children.
    Chonmaitree T; Congeni BL; Munoz J; Rakusan TA; Powell KR; Box QT
    J Antimicrob Chemother; 1984 May; 13(5):511-6. PubMed ID: 6330022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.
    Maslow MJ; Levine JF; Pollock AA; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Jul; 22(1):103-7. PubMed ID: 6289735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily ceftriaxone for skin and soft tissue infections.
    Gordin FM; Wofsy CB; Mills J
    Antimicrob Agents Chemother; 1985 Apr; 27(4):648-9. PubMed ID: 4004197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ceftriaxone in serious bacterial infections.
    Epstein JS; Hasselquist SM; Simon GL
    Antimicrob Agents Chemother; 1982 Mar; 21(3):402-6. PubMed ID: 6285809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.
    Eron LJ; Goldenberg RI; Poretz DM
    Am J Surg; 1984 Oct; 148(4A):1-4. PubMed ID: 6091473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone administered once or twice a day for treatment of bacterial infections of childhood.
    Higham M; Cunningham FM; Teele DW
    Pediatr Infect Dis; 1985; 4(1):22-6. PubMed ID: 3969362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of ceftriaxone in the pediatric field].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone in the treatment of infections caused by Staphylococcus aureus in children.
    Nelson SJ; Boies EG; Shackelford PG
    Pediatr Infect Dis; 1985; 4(1):27-31. PubMed ID: 3969363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily ceftriaxone therapy for serious bacterial infections in children.
    Congeni BL; Chonmaitree T; Rakusan TA; Box QT
    Antimicrob Agents Chemother; 1985 Feb; 27(2):181-3. PubMed ID: 3985602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone for the treatment of serious infections.
    Steele RW; Bradsher RW
    Am J Dis Child; 1983 Nov; 137(11):1044-7. PubMed ID: 6314805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone (Ro 13-9904) therapy of serious infection.
    Bradsher RW
    Antimicrob Agents Chemother; 1982 Jul; 22(1):36-42. PubMed ID: 6289739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.